Global Oral TYK2 Inhibitor Supply, Demand and Key Producers, 2024-2030
The global Oral TYK2 Inhibitor market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Oral TYK2 Inhibitor demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral TYK2 Inhibitor, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral TYK2 Inhibitor that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral TYK2 Inhibitor total market, 2019-2030, (USD Million)
Global Oral TYK2 Inhibitor total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Oral TYK2 Inhibitor total market, key domestic companies and share, (USD Million)
Global Oral TYK2 Inhibitor revenue by player and market share 2019-2024, (USD Million)
Global Oral TYK2 Inhibitor total market by Type, CAGR, 2019-2030, (USD Million)
Global Oral TYK2 Inhibitor total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Oral TYK2 Inhibitor market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), E-nitiate Biopharmaceuticals, Highlightll Pharmaceutical, Pfizer, Alumis Inc., Galapagos NV and Ventyx Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral TYK2 Inhibitor market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Oral TYK2 Inhibitor Market, By Region:
1. How big is the global Oral TYK2 Inhibitor market?
2. What is the demand of the global Oral TYK2 Inhibitor market?
3. What is the year over year growth of the global Oral TYK2 Inhibitor market?
4. What is the total value of the global Oral TYK2 Inhibitor market?
5. Who are the major players in the global Oral TYK2 Inhibitor market?
This report studies the global Oral TYK2 Inhibitor demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral TYK2 Inhibitor, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral TYK2 Inhibitor that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral TYK2 Inhibitor total market, 2019-2030, (USD Million)
Global Oral TYK2 Inhibitor total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Oral TYK2 Inhibitor total market, key domestic companies and share, (USD Million)
Global Oral TYK2 Inhibitor revenue by player and market share 2019-2024, (USD Million)
Global Oral TYK2 Inhibitor total market by Type, CAGR, 2019-2030, (USD Million)
Global Oral TYK2 Inhibitor total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Oral TYK2 Inhibitor market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), E-nitiate Biopharmaceuticals, Highlightll Pharmaceutical, Pfizer, Alumis Inc., Galapagos NV and Ventyx Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral TYK2 Inhibitor market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Oral TYK2 Inhibitor Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single-target Inhibitor
- Dual-target Inhibitor
- Psoriasis
- Atopic Dermatitis
- Other
- Bristol-Myers Squibb
- InnoCare Pharma
- Takeda (Nimbus Therapeutics)
- E-nitiate Biopharmaceuticals
- Highlightll Pharmaceutical
- Pfizer
- Alumis Inc.
- Galapagos NV
- Ventyx Biosciences
1. How big is the global Oral TYK2 Inhibitor market?
2. What is the demand of the global Oral TYK2 Inhibitor market?
3. What is the year over year growth of the global Oral TYK2 Inhibitor market?
4. What is the total value of the global Oral TYK2 Inhibitor market?
5. Who are the major players in the global Oral TYK2 Inhibitor market?
1 SUPPLY SUMMARY
1.1 Oral TYK2 Inhibitor Introduction
1.2 World Oral TYK2 Inhibitor Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Oral TYK2 Inhibitor Total Market by Region (by Headquarter Location)
1.3.1 World Oral TYK2 Inhibitor Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.3 China Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.4 Europe Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.5 Japan Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.6 South Korea Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.7 ASEAN Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.8 India Oral TYK2 Inhibitor Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral TYK2 Inhibitor Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral TYK2 Inhibitor Major Market Trends
2 DEMAND SUMMARY
2.1 World Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.2 World Oral TYK2 Inhibitor Consumption Value by Region
2.2.1 World Oral TYK2 Inhibitor Consumption Value by Region (2019-2024)
2.2.2 World Oral TYK2 Inhibitor Consumption Value Forecast by Region (2025-2030)
2.3 United States Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.4 China Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.5 Europe Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.6 Japan Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.7 South Korea Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.8 ASEAN Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.9 India Oral TYK2 Inhibitor Consumption Value (2019-2030)
3 WORLD ORAL TYK2 INHIBITOR COMPANIES COMPETITIVE ANALYSIS
3.1 World Oral TYK2 Inhibitor Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oral TYK2 Inhibitor Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oral TYK2 Inhibitor in 2023
3.2.3 Global Concentration Ratios (CR8) for Oral TYK2 Inhibitor in 2023
3.3 Oral TYK2 Inhibitor Company Evaluation Quadrant
3.4 Oral TYK2 Inhibitor Market: Overall Company Footprint Analysis
3.4.1 Oral TYK2 Inhibitor Market: Region Footprint
3.4.2 Oral TYK2 Inhibitor Market: Company Product Type Footprint
3.4.3 Oral TYK2 Inhibitor Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oral TYK2 Inhibitor Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oral TYK2 Inhibitor Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Oral TYK2 Inhibitor Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Oral TYK2 Inhibitor Consumption Value Comparison
4.2.1 United States VS China: Oral TYK2 Inhibitor Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Oral TYK2 Inhibitor Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Oral TYK2 Inhibitor Companies and Market Share, 2019-2024
4.3.1 United States Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024)
4.4 China Based Companies Oral TYK2 Inhibitor Revenue and Market Share, 2019-2024
4.4.1 China Based Oral TYK2 Inhibitor Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024)
4.5 Rest of World Based Oral TYK2 Inhibitor Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral TYK2 Inhibitor Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Single-target Inhibitor
5.2.2 Dual-target Inhibitor
5.3 Market Segment by Type
5.3.1 World Oral TYK2 Inhibitor Market Size by Type (2019-2024)
5.3.2 World Oral TYK2 Inhibitor Market Size by Type (2025-2030)
5.3.3 World Oral TYK2 Inhibitor Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral TYK2 Inhibitor Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Psoriasis
6.2.2 Atopic Dermatitis
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Oral TYK2 Inhibitor Market Size by Application (2019-2024)
6.3.2 World Oral TYK2 Inhibitor Market Size by Application (2025-2030)
6.3.3 World Oral TYK2 Inhibitor Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Details
7.1.2 Bristol-Myers Squibb Major Business
7.1.3 Bristol-Myers Squibb Oral TYK2 Inhibitor Product and Services
7.1.4 Bristol-Myers Squibb Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Bristol-Myers Squibb Recent Developments/Updates
7.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.2 InnoCare Pharma
7.2.1 InnoCare Pharma Details
7.2.2 InnoCare Pharma Major Business
7.2.3 InnoCare Pharma Oral TYK2 Inhibitor Product and Services
7.2.4 InnoCare Pharma Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 InnoCare Pharma Recent Developments/Updates
7.2.6 InnoCare Pharma Competitive Strengths & Weaknesses
7.3 Takeda (Nimbus Therapeutics)
7.3.1 Takeda (Nimbus Therapeutics) Details
7.3.2 Takeda (Nimbus Therapeutics) Major Business
7.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product and Services
7.3.4 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Takeda (Nimbus Therapeutics) Recent Developments/Updates
7.3.6 Takeda (Nimbus Therapeutics) Competitive Strengths & Weaknesses
7.4 E-nitiate Biopharmaceuticals
7.4.1 E-nitiate Biopharmaceuticals Details
7.4.2 E-nitiate Biopharmaceuticals Major Business
7.4.3 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product and Services
7.4.4 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 E-nitiate Biopharmaceuticals Recent Developments/Updates
7.4.6 E-nitiate Biopharmaceuticals Competitive Strengths & Weaknesses
7.5 Highlightll Pharmaceutical
7.5.1 Highlightll Pharmaceutical Details
7.5.2 Highlightll Pharmaceutical Major Business
7.5.3 Highlightll Pharmaceutical Oral TYK2 Inhibitor Product and Services
7.5.4 Highlightll Pharmaceutical Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Highlightll Pharmaceutical Recent Developments/Updates
7.5.6 Highlightll Pharmaceutical Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Oral TYK2 Inhibitor Product and Services
7.6.4 Pfizer Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Alumis Inc.
7.7.1 Alumis Inc. Details
7.7.2 Alumis Inc. Major Business
7.7.3 Alumis Inc. Oral TYK2 Inhibitor Product and Services
7.7.4 Alumis Inc. Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Alumis Inc. Recent Developments/Updates
7.7.6 Alumis Inc. Competitive Strengths & Weaknesses
7.8 Galapagos NV
7.8.1 Galapagos NV Details
7.8.2 Galapagos NV Major Business
7.8.3 Galapagos NV Oral TYK2 Inhibitor Product and Services
7.8.4 Galapagos NV Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Galapagos NV Recent Developments/Updates
7.8.6 Galapagos NV Competitive Strengths & Weaknesses
7.9 Ventyx Biosciences
7.9.1 Ventyx Biosciences Details
7.9.2 Ventyx Biosciences Major Business
7.9.3 Ventyx Biosciences Oral TYK2 Inhibitor Product and Services
7.9.4 Ventyx Biosciences Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Ventyx Biosciences Recent Developments/Updates
7.9.6 Ventyx Biosciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oral TYK2 Inhibitor Industry Chain
8.2 Oral TYK2 Inhibitor Upstream Analysis
8.3 Oral TYK2 Inhibitor Midstream Analysis
8.4 Oral TYK2 Inhibitor Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oral TYK2 Inhibitor Introduction
1.2 World Oral TYK2 Inhibitor Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Oral TYK2 Inhibitor Total Market by Region (by Headquarter Location)
1.3.1 World Oral TYK2 Inhibitor Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.3 China Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.4 Europe Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.5 Japan Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.6 South Korea Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.7 ASEAN Oral TYK2 Inhibitor Market Size (2019-2030)
1.3.8 India Oral TYK2 Inhibitor Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral TYK2 Inhibitor Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral TYK2 Inhibitor Major Market Trends
2 DEMAND SUMMARY
2.1 World Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.2 World Oral TYK2 Inhibitor Consumption Value by Region
2.2.1 World Oral TYK2 Inhibitor Consumption Value by Region (2019-2024)
2.2.2 World Oral TYK2 Inhibitor Consumption Value Forecast by Region (2025-2030)
2.3 United States Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.4 China Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.5 Europe Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.6 Japan Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.7 South Korea Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.8 ASEAN Oral TYK2 Inhibitor Consumption Value (2019-2030)
2.9 India Oral TYK2 Inhibitor Consumption Value (2019-2030)
3 WORLD ORAL TYK2 INHIBITOR COMPANIES COMPETITIVE ANALYSIS
3.1 World Oral TYK2 Inhibitor Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oral TYK2 Inhibitor Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oral TYK2 Inhibitor in 2023
3.2.3 Global Concentration Ratios (CR8) for Oral TYK2 Inhibitor in 2023
3.3 Oral TYK2 Inhibitor Company Evaluation Quadrant
3.4 Oral TYK2 Inhibitor Market: Overall Company Footprint Analysis
3.4.1 Oral TYK2 Inhibitor Market: Region Footprint
3.4.2 Oral TYK2 Inhibitor Market: Company Product Type Footprint
3.4.3 Oral TYK2 Inhibitor Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oral TYK2 Inhibitor Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oral TYK2 Inhibitor Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Oral TYK2 Inhibitor Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Oral TYK2 Inhibitor Consumption Value Comparison
4.2.1 United States VS China: Oral TYK2 Inhibitor Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Oral TYK2 Inhibitor Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Oral TYK2 Inhibitor Companies and Market Share, 2019-2024
4.3.1 United States Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024)
4.4 China Based Companies Oral TYK2 Inhibitor Revenue and Market Share, 2019-2024
4.4.1 China Based Oral TYK2 Inhibitor Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024)
4.5 Rest of World Based Oral TYK2 Inhibitor Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral TYK2 Inhibitor Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Single-target Inhibitor
5.2.2 Dual-target Inhibitor
5.3 Market Segment by Type
5.3.1 World Oral TYK2 Inhibitor Market Size by Type (2019-2024)
5.3.2 World Oral TYK2 Inhibitor Market Size by Type (2025-2030)
5.3.3 World Oral TYK2 Inhibitor Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral TYK2 Inhibitor Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Psoriasis
6.2.2 Atopic Dermatitis
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Oral TYK2 Inhibitor Market Size by Application (2019-2024)
6.3.2 World Oral TYK2 Inhibitor Market Size by Application (2025-2030)
6.3.3 World Oral TYK2 Inhibitor Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Details
7.1.2 Bristol-Myers Squibb Major Business
7.1.3 Bristol-Myers Squibb Oral TYK2 Inhibitor Product and Services
7.1.4 Bristol-Myers Squibb Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Bristol-Myers Squibb Recent Developments/Updates
7.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.2 InnoCare Pharma
7.2.1 InnoCare Pharma Details
7.2.2 InnoCare Pharma Major Business
7.2.3 InnoCare Pharma Oral TYK2 Inhibitor Product and Services
7.2.4 InnoCare Pharma Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 InnoCare Pharma Recent Developments/Updates
7.2.6 InnoCare Pharma Competitive Strengths & Weaknesses
7.3 Takeda (Nimbus Therapeutics)
7.3.1 Takeda (Nimbus Therapeutics) Details
7.3.2 Takeda (Nimbus Therapeutics) Major Business
7.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product and Services
7.3.4 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Takeda (Nimbus Therapeutics) Recent Developments/Updates
7.3.6 Takeda (Nimbus Therapeutics) Competitive Strengths & Weaknesses
7.4 E-nitiate Biopharmaceuticals
7.4.1 E-nitiate Biopharmaceuticals Details
7.4.2 E-nitiate Biopharmaceuticals Major Business
7.4.3 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product and Services
7.4.4 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 E-nitiate Biopharmaceuticals Recent Developments/Updates
7.4.6 E-nitiate Biopharmaceuticals Competitive Strengths & Weaknesses
7.5 Highlightll Pharmaceutical
7.5.1 Highlightll Pharmaceutical Details
7.5.2 Highlightll Pharmaceutical Major Business
7.5.3 Highlightll Pharmaceutical Oral TYK2 Inhibitor Product and Services
7.5.4 Highlightll Pharmaceutical Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Highlightll Pharmaceutical Recent Developments/Updates
7.5.6 Highlightll Pharmaceutical Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Oral TYK2 Inhibitor Product and Services
7.6.4 Pfizer Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Alumis Inc.
7.7.1 Alumis Inc. Details
7.7.2 Alumis Inc. Major Business
7.7.3 Alumis Inc. Oral TYK2 Inhibitor Product and Services
7.7.4 Alumis Inc. Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Alumis Inc. Recent Developments/Updates
7.7.6 Alumis Inc. Competitive Strengths & Weaknesses
7.8 Galapagos NV
7.8.1 Galapagos NV Details
7.8.2 Galapagos NV Major Business
7.8.3 Galapagos NV Oral TYK2 Inhibitor Product and Services
7.8.4 Galapagos NV Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Galapagos NV Recent Developments/Updates
7.8.6 Galapagos NV Competitive Strengths & Weaknesses
7.9 Ventyx Biosciences
7.9.1 Ventyx Biosciences Details
7.9.2 Ventyx Biosciences Major Business
7.9.3 Ventyx Biosciences Oral TYK2 Inhibitor Product and Services
7.9.4 Ventyx Biosciences Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Ventyx Biosciences Recent Developments/Updates
7.9.6 Ventyx Biosciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oral TYK2 Inhibitor Industry Chain
8.2 Oral TYK2 Inhibitor Upstream Analysis
8.3 Oral TYK2 Inhibitor Midstream Analysis
8.4 Oral TYK2 Inhibitor Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oral TYK2 Inhibitor Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Oral TYK2 Inhibitor Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Oral TYK2 Inhibitor Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Oral TYK2 Inhibitor Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Oral TYK2 Inhibitor Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oral TYK2 Inhibitor Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Oral TYK2 Inhibitor Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Oral TYK2 Inhibitor Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Oral TYK2 Inhibitor Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Oral TYK2 Inhibitor Players in 2023
Table 12. World Oral TYK2 Inhibitor Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Oral TYK2 Inhibitor Company Evaluation Quadrant
Table 14. Head Office of Key Oral TYK2 Inhibitor Player
Table 15. Oral TYK2 Inhibitor Market: Company Product Type Footprint
Table 16. Oral TYK2 Inhibitor Market: Company Product Application Footprint
Table 17. Oral TYK2 Inhibitor Mergers & Acquisitions Activity
Table 18. United States VS China Oral TYK2 Inhibitor Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Oral TYK2 Inhibitor Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Oral TYK2 Inhibitor Revenue Market Share (2019-2024)
Table 23. China Based Oral TYK2 Inhibitor Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Oral TYK2 Inhibitor Revenue Market Share (2019-2024)
Table 26. Rest of World Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Oral TYK2 Inhibitor Revenue Market Share (2019-2024)
Table 29. World Oral TYK2 Inhibitor Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Oral TYK2 Inhibitor Market Size by Type (2019-2024) & (USD Million)
Table 31. World Oral TYK2 Inhibitor Market Size by Type (2025-2030) & (USD Million)
Table 32. World Oral TYK2 Inhibitor Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Oral TYK2 Inhibitor Market Size by Application (2019-2024) & (USD Million)
Table 34. World Oral TYK2 Inhibitor Market Size by Application (2025-2030) & (USD Million)
Table 35. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 36. Bristol-Myers Squibb Major Business
Table 37. Bristol-Myers Squibb Oral TYK2 Inhibitor Product and Services
Table 38. Bristol-Myers Squibb Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Bristol-Myers Squibb Recent Developments/Updates
Table 40. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 41. InnoCare Pharma Basic Information, Area Served and Competitors
Table 42. InnoCare Pharma Major Business
Table 43. InnoCare Pharma Oral TYK2 Inhibitor Product and Services
Table 44. InnoCare Pharma Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. InnoCare Pharma Recent Developments/Updates
Table 46. InnoCare Pharma Competitive Strengths & Weaknesses
Table 47. Takeda (Nimbus Therapeutics) Basic Information, Area Served and Competitors
Table 48. Takeda (Nimbus Therapeutics) Major Business
Table 49. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product and Services
Table 50. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Takeda (Nimbus Therapeutics) Recent Developments/Updates
Table 52. Takeda (Nimbus Therapeutics) Competitive Strengths & Weaknesses
Table 53. E-nitiate Biopharmaceuticals Basic Information, Area Served and Competitors
Table 54. E-nitiate Biopharmaceuticals Major Business
Table 55. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product and Services
Table 56. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. E-nitiate Biopharmaceuticals Recent Developments/Updates
Table 58. E-nitiate Biopharmaceuticals Competitive Strengths & Weaknesses
Table 59. Highlightll Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Highlightll Pharmaceutical Major Business
Table 61. Highlightll Pharmaceutical Oral TYK2 Inhibitor Product and Services
Table 62. Highlightll Pharmaceutical Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Highlightll Pharmaceutical Recent Developments/Updates
Table 64. Highlightll Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Oral TYK2 Inhibitor Product and Services
Table 68. Pfizer Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Alumis Inc. Basic Information, Area Served and Competitors
Table 72. Alumis Inc. Major Business
Table 73. Alumis Inc. Oral TYK2 Inhibitor Product and Services
Table 74. Alumis Inc. Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Alumis Inc. Recent Developments/Updates
Table 76. Alumis Inc. Competitive Strengths & Weaknesses
Table 77. Galapagos NV Basic Information, Area Served and Competitors
Table 78. Galapagos NV Major Business
Table 79. Galapagos NV Oral TYK2 Inhibitor Product and Services
Table 80. Galapagos NV Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Galapagos NV Recent Developments/Updates
Table 82. Ventyx Biosciences Basic Information, Area Served and Competitors
Table 83. Ventyx Biosciences Major Business
Table 84. Ventyx Biosciences Oral TYK2 Inhibitor Product and Services
Table 85. Ventyx Biosciences Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 86. Global Key Players of Oral TYK2 Inhibitor Upstream (Raw Materials)
Table 87. Oral TYK2 Inhibitor Typical Customers
List of Figure
Figure 1. Oral TYK2 Inhibitor Picture
Figure 2. World Oral TYK2 Inhibitor Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Oral TYK2 Inhibitor Total Market Size (2019-2030) & (USD Million)
Figure 4. World Oral TYK2 Inhibitor Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Oral TYK2 Inhibitor Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 13. Oral TYK2 Inhibitor Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 16. World Oral TYK2 Inhibitor Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 18. China Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 23. India Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Oral TYK2 Inhibitor by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oral TYK2 Inhibitor Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oral TYK2 Inhibitor Markets in 2023
Figure 27. United States VS China: Oral TYK2 Inhibitor Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Oral TYK2 Inhibitor Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Oral TYK2 Inhibitor Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Oral TYK2 Inhibitor Market Size Market Share by Type in 2023
Figure 31. Single-target Inhibitor
Figure 32. Dual-target Inhibitor
Figure 33. World Oral TYK2 Inhibitor Market Size Market Share by Type (2019-2030)
Figure 34. World Oral TYK2 Inhibitor Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Oral TYK2 Inhibitor Market Size Market Share by Application in 2023
Figure 36. Psoriasis
Figure 37. Atopic Dermatitis
Figure 38. Other
Figure 39. Oral TYK2 Inhibitor Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Oral TYK2 Inhibitor Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Oral TYK2 Inhibitor Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Oral TYK2 Inhibitor Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Oral TYK2 Inhibitor Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Oral TYK2 Inhibitor Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oral TYK2 Inhibitor Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Oral TYK2 Inhibitor Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Oral TYK2 Inhibitor Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Oral TYK2 Inhibitor Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Oral TYK2 Inhibitor Players in 2023
Table 12. World Oral TYK2 Inhibitor Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Oral TYK2 Inhibitor Company Evaluation Quadrant
Table 14. Head Office of Key Oral TYK2 Inhibitor Player
Table 15. Oral TYK2 Inhibitor Market: Company Product Type Footprint
Table 16. Oral TYK2 Inhibitor Market: Company Product Application Footprint
Table 17. Oral TYK2 Inhibitor Mergers & Acquisitions Activity
Table 18. United States VS China Oral TYK2 Inhibitor Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Oral TYK2 Inhibitor Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Oral TYK2 Inhibitor Revenue Market Share (2019-2024)
Table 23. China Based Oral TYK2 Inhibitor Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Oral TYK2 Inhibitor Revenue Market Share (2019-2024)
Table 26. Rest of World Based Oral TYK2 Inhibitor Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Oral TYK2 Inhibitor Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Oral TYK2 Inhibitor Revenue Market Share (2019-2024)
Table 29. World Oral TYK2 Inhibitor Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Oral TYK2 Inhibitor Market Size by Type (2019-2024) & (USD Million)
Table 31. World Oral TYK2 Inhibitor Market Size by Type (2025-2030) & (USD Million)
Table 32. World Oral TYK2 Inhibitor Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Oral TYK2 Inhibitor Market Size by Application (2019-2024) & (USD Million)
Table 34. World Oral TYK2 Inhibitor Market Size by Application (2025-2030) & (USD Million)
Table 35. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 36. Bristol-Myers Squibb Major Business
Table 37. Bristol-Myers Squibb Oral TYK2 Inhibitor Product and Services
Table 38. Bristol-Myers Squibb Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Bristol-Myers Squibb Recent Developments/Updates
Table 40. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 41. InnoCare Pharma Basic Information, Area Served and Competitors
Table 42. InnoCare Pharma Major Business
Table 43. InnoCare Pharma Oral TYK2 Inhibitor Product and Services
Table 44. InnoCare Pharma Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. InnoCare Pharma Recent Developments/Updates
Table 46. InnoCare Pharma Competitive Strengths & Weaknesses
Table 47. Takeda (Nimbus Therapeutics) Basic Information, Area Served and Competitors
Table 48. Takeda (Nimbus Therapeutics) Major Business
Table 49. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product and Services
Table 50. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Takeda (Nimbus Therapeutics) Recent Developments/Updates
Table 52. Takeda (Nimbus Therapeutics) Competitive Strengths & Weaknesses
Table 53. E-nitiate Biopharmaceuticals Basic Information, Area Served and Competitors
Table 54. E-nitiate Biopharmaceuticals Major Business
Table 55. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product and Services
Table 56. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. E-nitiate Biopharmaceuticals Recent Developments/Updates
Table 58. E-nitiate Biopharmaceuticals Competitive Strengths & Weaknesses
Table 59. Highlightll Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Highlightll Pharmaceutical Major Business
Table 61. Highlightll Pharmaceutical Oral TYK2 Inhibitor Product and Services
Table 62. Highlightll Pharmaceutical Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Highlightll Pharmaceutical Recent Developments/Updates
Table 64. Highlightll Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Oral TYK2 Inhibitor Product and Services
Table 68. Pfizer Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Alumis Inc. Basic Information, Area Served and Competitors
Table 72. Alumis Inc. Major Business
Table 73. Alumis Inc. Oral TYK2 Inhibitor Product and Services
Table 74. Alumis Inc. Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Alumis Inc. Recent Developments/Updates
Table 76. Alumis Inc. Competitive Strengths & Weaknesses
Table 77. Galapagos NV Basic Information, Area Served and Competitors
Table 78. Galapagos NV Major Business
Table 79. Galapagos NV Oral TYK2 Inhibitor Product and Services
Table 80. Galapagos NV Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Galapagos NV Recent Developments/Updates
Table 82. Ventyx Biosciences Basic Information, Area Served and Competitors
Table 83. Ventyx Biosciences Major Business
Table 84. Ventyx Biosciences Oral TYK2 Inhibitor Product and Services
Table 85. Ventyx Biosciences Oral TYK2 Inhibitor Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 86. Global Key Players of Oral TYK2 Inhibitor Upstream (Raw Materials)
Table 87. Oral TYK2 Inhibitor Typical Customers
List of Figure
Figure 1. Oral TYK2 Inhibitor Picture
Figure 2. World Oral TYK2 Inhibitor Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Oral TYK2 Inhibitor Total Market Size (2019-2030) & (USD Million)
Figure 4. World Oral TYK2 Inhibitor Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Oral TYK2 Inhibitor Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Oral TYK2 Inhibitor Revenue (2019-2030) & (USD Million)
Figure 13. Oral TYK2 Inhibitor Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 16. World Oral TYK2 Inhibitor Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 18. China Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 23. India Oral TYK2 Inhibitor Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Oral TYK2 Inhibitor by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oral TYK2 Inhibitor Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oral TYK2 Inhibitor Markets in 2023
Figure 27. United States VS China: Oral TYK2 Inhibitor Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Oral TYK2 Inhibitor Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Oral TYK2 Inhibitor Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Oral TYK2 Inhibitor Market Size Market Share by Type in 2023
Figure 31. Single-target Inhibitor
Figure 32. Dual-target Inhibitor
Figure 33. World Oral TYK2 Inhibitor Market Size Market Share by Type (2019-2030)
Figure 34. World Oral TYK2 Inhibitor Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Oral TYK2 Inhibitor Market Size Market Share by Application in 2023
Figure 36. Psoriasis
Figure 37. Atopic Dermatitis
Figure 38. Other
Figure 39. Oral TYK2 Inhibitor Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
